Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma; METT

Press/Media: Press / Media

Period2018 Oct 2

Media coverage

1

Media coverage

  • TitleStudy on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma; METT
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date18/10/2
    Personsminjung Kim